Table 4.

Comparison of Reevaluation Method of Medical Technology in Japan and Korea.

Reevaluation	South Korea	Japan
CED-driven	Reevaluation for CSB:	Reevaluation for CA:
	• Consider four components	• The process for reevaluation after granting CA eligibility is similar to that of C1 category application regardless of initial application categories
	-Clinical usefulness
	-Cost-effectiveness
	-Replaceability
	-Social demand on reimbursement
Non-CED-driven	Functional category reevaluation:	Not available
	• Review cost, effectiveness, and performance of listed items
	• Adjust reimbursement price with the weighted average by applying claim volumes and prices

CED, coverage with evidence development; CA, challenge application; CSB, conditional selective benefit